Literature DB >> 21649668

Alteration of ethanol drinking in mice via modulation of the GABA(A) receptor with ganaxolone, finasteride, and gaboxadol.

Marcia J Ramaker1, Matthew M Ford, Andrea M Fretwell, Deborah A Finn.   

Abstract

BACKGROUND: Neurosteroids and other γ-aminobutyric acid(A) (GABA(A) ) receptor-modulating compounds have been shown to affect ethanol intake, although their mechanism remains unclear. This study examined how patterns of 24-hour ethanol drinking in mice were altered with the synthetic GABAergic neurosteroid ganaxolone (GAN), with an inhibitor of neurosteroid synthesis (finasteride [FIN]), or a GABA(A) receptor agonist with some selectivity at extrasynaptic receptors (gaboxadol HCL [THIP]).
METHODS: Male C57BL/6J mice had continuous access to a 10% v/v ethanol solution (10E) or water. Using lickometer chambers, drinking patterns were analyzed among mice treated in succession to GAN (0, 5, and 10 mg/kg), FIN (0 or 100 mg/kg), and THIP (0, 2, 4, 8, and 16 mg/kg).
RESULTS: GAN shifted drinking in a similar but extended manner to previous reports using low doses of the neurosteroid allopregnanolone (ALLO); drinking was increased in hour 1, decreased in hours 2 and 3, and increased in hours 4 and 5 postinjection. THIP (8 mg/kg) and FIN both decreased 10E drinking during the first 5 hours postinjection by 30 and 53%, respectively, while having no effect on or increasing water drinking, respectively. All 3 drugs altered the initiation of drinking sessions in a dose-dependent fashion. FIN increased and GAN decreased time to first lick and first bout. THIP (8 mg/kg) decreased time to first lick but increased time to first bout and attenuated first bout size.
CONCLUSIONS: The present findings support a role for the modulation of ethanol intake by neurosteroids and GABA(A) receptor-acting compounds and provide hints as to how drinking patterns are shifted. The ability of THIP to alter 10E drinking suggests that extrasynaptic GABA(A) receptors may be involved in the modulation of ethanol intake. Further, the consistent results with THIP to that seen previously with high doses of ALLO suggest that future studies should further examine the relationship between neurosteroids and extrasynaptic GABA(A) receptors, which could provide a better understanding of the mechanism by which neurosteroids influence ethanol intake.
Copyright © 2011 by the Research Society on Alcoholism.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21649668      PMCID: PMC3173599          DOI: 10.1111/j.1530-0277.2011.01551.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  65 in total

1.  GABA(A) receptors: immunocytochemical distribution of 13 subunits in the adult rat brain.

Authors:  S Pirker; C Schwarzer; A Wieselthaler; W Sieghart; G Sperk
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

Review 2.  Neuroactive steroids: potential therapeutic use in neurological and psychiatric disorders.

Authors:  M Gasior; R B Carter; J M Witkin
Journal:  Trends Pharmacol Sci       Date:  1999-03       Impact factor: 14.819

3.  GABA(A) receptors containing (alpha)5 subunits in the CA1 and CA3 hippocampal fields regulate ethanol-motivated behaviors: an extended ethanol reward circuitry.

Authors:  H L June; S C Harvey; K L Foster; P F McKay; R Cummings; M Garcia; D Mason; C Grey; S McCane; L S Williams; T B Johnson; X He; S Rock; J M Cook
Journal:  J Neurosci       Date:  2001-03-15       Impact factor: 6.167

4.  Attenuated sensitivity to neuroactive steroids in gamma-aminobutyrate type A receptor delta subunit knockout mice.

Authors:  R M Mihalek; P K Banerjee; E R Korpi; J J Quinlan; L L Firestone; Z P Mi; C Lagenaur; V Tretter; W Sieghart; S G Anagnostaras; J R Sage; M S Fanselow; A Guidotti; I Spigelman; Z Li; T M DeLorey; R W Olsen; G E Homanics
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

5.  Allopregnanolone and pentobarbital infused into the nucleus accumbens substitute for the discriminative stimulus effects of ethanol.

Authors:  C W Hodge; M A Nannini; M F Olive; S P Kelley; K K Mehmert
Journal:  Alcohol Clin Exp Res       Date:  2001-10       Impact factor: 3.455

6.  Muscimol injected into the medial prefrontal cortex of the rat alters ethanol self-administration.

Authors:  H H Samson; A Chappell
Journal:  Physiol Behav       Date:  2001 Nov-Dec

7.  Revising the preventive paradox: the Swiss case.

Authors:  G Gmel; S Klingemann; R Müller; D Brenner
Journal:  Addiction       Date:  2001-02       Impact factor: 6.526

8.  Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis.

Authors:  Stephanie S O'Malley; Suchitra Krishnan-Sarin; Conor Farren; Rajita Sinha; Mary Jeanne Kreek
Journal:  Psychopharmacology (Berl)       Date:  2002-01-22       Impact factor: 4.530

9.  Chronic treatment with the neuroactive steroid ganaxolone in the rat induces anticonvulsant tolerance to diazepam but not to itself.

Authors:  D S Reddy; M A Rogawski
Journal:  J Pharmacol Exp Ther       Date:  2000-12       Impact factor: 4.030

10.  Pharmacological characterization of a novel cell line expressing human alpha(4)beta(3)delta GABA(A) receptors.

Authors:  N Brown; J Kerby; T P Bonnert; P J Whiting; K A Wafford
Journal:  Br J Pharmacol       Date:  2002-08       Impact factor: 8.739

View more
  18 in total

1.  The Cerebellar GABAAR System as a Potential Target for Treating Alcohol Use Disorder.

Authors:  David J Rossi; Ben D Richardson
Journal:  Handb Exp Pharmacol       Date:  2018

2.  Effect of nucleus accumbens shell infusions of ganaxolone or gaboxadol on ethanol consumption in mice.

Authors:  Marcia J Ramaker; Moriah N Strong-Kaufman; Matthew M Ford; Tamara J Phillips; Deborah A Finn
Journal:  Psychopharmacology (Berl)       Date:  2014-10-25       Impact factor: 4.530

3.  Effect of ganaxolone and THIP on operant and limited-access ethanol self-administration.

Authors:  Marcia J Ramaker; Moriah N Strong; Matthew M Ford; Deborah A Finn
Journal:  Neuropharmacology       Date:  2012-05-18       Impact factor: 5.250

4.  Site-specific microinjection of Gaboxadol into the infralimbic cortex modulates ethanol intake in male C57BL/6J mice.

Authors:  Brandon M Fritz; Stephen L Boehm
Journal:  Behav Brain Res       Date:  2014-07-18       Impact factor: 3.332

5.  Effects of different ethanol-administration regimes on mRNA and protein levels of steroid 5α-reductase isozymes in prefrontal cortex of adolescent male rats.

Authors:  Pilar Sánchez; Beatriz Castro; Jesús M Torres; Esperanza Ortega
Journal:  Psychopharmacology (Berl)       Date:  2014-04-09       Impact factor: 4.530

Review 6.  Rodent models and mechanisms of voluntary binge-like ethanol consumption: Examples, opportunities, and strategies for preclinical research.

Authors:  Brandon M Fritz; Stephen L Boehm
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2015-06-02       Impact factor: 5.067

7.  Differences in the reinstatement of ethanol seeking with ganaxolone and gaboxadol.

Authors:  M J Ramaker; M M Ford; T J Phillips; D A Finn
Journal:  Neuroscience       Date:  2014-05-09       Impact factor: 3.590

8.  Dutasteride reduces alcohol's sedative effects in men in a human laboratory setting and reduces drinking in the natural environment.

Authors:  Jonathan Covault; Timothy Pond; Richard Feinn; Albert J Arias; Cheryl Oncken; Henry R Kranzler
Journal:  Psychopharmacology (Berl)       Date:  2014-02-21       Impact factor: 4.530

Review 9.  A Rationale for Allopregnanolone Treatment of Alcohol Use Disorders: Basic and Clinical Studies.

Authors:  A Leslie Morrow; Giorgia Boero; Patrizia Porcu
Journal:  Alcohol Clin Exp Res       Date:  2019-12-17       Impact factor: 3.455

10.  Persistent escalation of alcohol consumption by mice exposed to brief episodes of social defeat stress: suppression by CRF-R1 antagonism.

Authors:  Emily L Newman; Lucas Albrechet-Souza; Peter M Andrew; John G Auld; Kelly C Burk; Lara S Hwa; Eric Y Zhang; Joseph F DeBold; Klaus A Miczek
Journal:  Psychopharmacology (Berl)       Date:  2018-04-25       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.